Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FluoAB is a fluorescently labeled human immunoglobulin G (IgG) probe developed by the Chinese Academy of Sciences for intraoperative imaging of liver tumors. It is designed to assist surgeons during hepatectomy by providing real-time fluorescence guidance to distinguish between malignant tumor tissue and liver cirrhosis or normal parenchyma. The probe utilizes the accumulation properties of IgG within the tumor microenvironment to enable visualization under specialized imaging equipment. By enhancing the precision of surgical margins, FluoAB aims to improve the safety and effectiveness of hepatic cancer resections.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on FluoAB.